22 results
6-K
LEGN
Legend Biotech Corp
13 May 24
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
7:01am
31,2023
US$’000(Unaudited)
US$’000
Raw materials
Work-in-process
Finished goods
Total collaboration inventories
The Company's reserve for inventory … , including regulatory approval and pricing determinations; disruptions to access to raw materials; delays or disruptions at manufacturing facilities
6-K
LEGN
Legend Biotech Corp
29 Mar 24
Current report (foreign)
8:00am
of certain raw materials used in manufacturing the Product.
The Agreement also includes customary representations and warranties and covenants relating
F-3ASR
LEGN
Legend Biotech Corp
19 Mar 24
Automatic shelf registration (foreign)
7:57am
we may develop, if approved;
information about the prices and availability of labor, transportation and raw materials, including as a result … on acceptable terms, if at all.
Our inability to obtain or manufacture raw materials or key starting materials necessary for product manufacture
6-K
LEGN
Legend Biotech Corp
20 Nov 23
Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights
6:02am
into:
Current portion
Non-current portion
Total
10. COLLABORATION INVENTORIES
September 30,2023
December 31,2022
US$’000(Unaudited)
US$’000
Raw materials
Work … to the evolving situation, commercialization factors, including regulatory approval and pricing determinations; disruptions to access to raw materials; delays
6-K
zzqv dvorqyb3dx
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
F-3ASR
a1nnlbgl acw5s
26 May 23
Automatic shelf registration (foreign)
9:01am
424B5
gxw7 ilqj
8 May 23
Prospectus supplement for primary offering
8:45am
6-K
EX-99.1
qctub g9w
14 Apr 23
Master Technology Transfer, Manufacturing and Clinical Supply Services Agreement for Bcma Car-t Product
8:30am
424B5
316q9um2zk3b1rziv
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
a15rw fpm8
25 Jul 22
Prospectus supplement for primary offering
4:29pm
6-K
EX-99.3
6ybmo4 vd2aoig
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
EX-99.3
2fgggvxd
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
cpn kyo4i
23 Aug 21
Current report (foreign)
8:16am
20-F
6wwsg6aad5j8x
2 Apr 21
Annual report (foreign)
8:10am
424B4
ypjgupn
8 Jun 20
Prospectus supplement with pricing info
9:07am
F-1/A
f6eie 83s7hnx
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1
ndwtil
13 May 20
Registration statement (foreign)
4:41pm